Cell Culture and Virus Vector Core

细胞培养和病毒载体核心

基本信息

项目摘要

Mission: The mission of the Cell and Viral Vector Core Laboratory (CWCL) is to support high quality research and enable CCC investigators to maximize productivity and remain competitive for extramural funding. Assets: This shared resource has three main assets which make it essential to the research mission of the Comprehensive Cancer Center. First, it provides consultation on molecular, cellular and viral techniques, leveraging the expertise of the Director and senior staff. Such consultation includes assisting investigators in the design, implementation and optimization of new procedures. Second, it provides specialized services and techniques not easily reproduced in investigators' laboratories. Some recent examples include cytotoxicity assays to evaluate prospective anticancer agents, modified focus formation assays to uncover novel oncogenes, expression of recombinant proteins using retroviral vectors or tetracycline-inducible vectors, and establishment of human and murine primary cell lines from tissue explants. Third, it provides subsidized access to critical cell culture and molecular biology reagents. Usage: The laboratory is used by nearly all of the Cancer Center members whose primary focus is basic science research. Usage of the Cell and Viral Vector Core Laboratory has increased each year since 2001, and is reflected in laboratory charge-backs which increased 85% between 2006 and 2009. Over 60% of the CWCL charge-back income in 2010 came from Cancer Center members with active cancer-related funding. Specialized cell culture services and the ready availability of reagents at a significant savings enhance the ability of our investigators to efficiently conduct research and support the research efforts of the Comprehensive Cancer Center and Wake Forest University. Future directions for the laboratory will include provision of two new services, cell line authentication, and standardized production of replication-incompetent viruses for gene transfer. These services are provided in response to changes in the field, and user requests.
使命:细胞和病毒载体核心实验室(CWCL)的使命是支持高质量

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISABELLE M BERQUIN其他文献

ISABELLE M BERQUIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISABELLE M BERQUIN', 18)}}的其他基金

Cell Culture and Virus Vector Core
细胞培养和病毒载体核心
  • 批准号:
    7529744
  • 财政年份:
    2007
  • 资助金额:
    $ 7.96万
  • 项目类别:
Role of YB-1 in EGFR regulation and breast cancer
YB-1 在 EGFR 调节和乳腺癌中的作用
  • 批准号:
    7267699
  • 财政年份:
    2006
  • 资助金额:
    $ 7.96万
  • 项目类别:
Role of YB-1 in EGFR regulation and breast cancer
YB-1 在 EGFR 调节和乳腺癌中的作用
  • 批准号:
    7458833
  • 财政年份:
    2006
  • 资助金额:
    $ 7.96万
  • 项目类别:
Role of YB-1 in EGFR regulation and breast cancer
YB-1 在 EGFR 调节和乳腺癌中的作用
  • 批准号:
    7148827
  • 财政年份:
    2006
  • 资助金额:
    $ 7.96万
  • 项目类别:
Role of YB-1 in EGFR regulation and breast cancer
YB-1 在 EGFR 调节和乳腺癌中的作用
  • 批准号:
    7629718
  • 财政年份:
    2006
  • 资助金额:
    $ 7.96万
  • 项目类别:
Role of YB-1 in EGFR regulation and breast cancer
YB-1 在 EGFR 调节和乳腺癌中的作用
  • 批准号:
    7858424
  • 财政年份:
    2006
  • 资助金额:
    $ 7.96万
  • 项目类别:
Cell Culture and Virus Vector Core
细胞培养和病毒载体核心
  • 批准号:
    9000111
  • 财政年份:
    1997
  • 资助金额:
    $ 7.96万
  • 项目类别:
Cell Culture and Virus Vector Core
细胞培养和病毒载体核心
  • 批准号:
    8016100
  • 财政年份:
  • 资助金额:
    $ 7.96万
  • 项目类别:
Cell Culture and Virus Vector Core
细胞培养和病毒载体核心
  • 批准号:
    8714174
  • 财政年份:
  • 资助金额:
    $ 7.96万
  • 项目类别:
Cell Culture and Virus Vector Core
细胞培养和病毒载体核心
  • 批准号:
    8567726
  • 财政年份:
  • 资助金额:
    $ 7.96万
  • 项目类别:

相似国自然基金

基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
  • 批准号:
    2024KP61
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
  • 批准号:
    51307073
  • 批准年份:
    2013
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
  • 批准号:
    2338816
  • 财政年份:
    2024
  • 资助金额:
    $ 7.96万
  • 项目类别:
    Continuing Grant
One-step reconstruction of plastic waste back to its constituent monomers (ONESTEP)
将塑料废物一步重建回其组成单体(ONESTEP)
  • 批准号:
    EP/Y003934/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.96万
  • 项目类别:
    Research Grant
On the origin of very massive back holes
关于巨大背洞的起源
  • 批准号:
    DP240101786
  • 财政年份:
    2024
  • 资助金额:
    $ 7.96万
  • 项目类别:
    Discovery Projects
Back to our roots: Re-activating Indigenous biocultural conservation
回到我们的根源:重新激活本土生物文化保护
  • 批准号:
    FT230100595
  • 财政年份:
    2024
  • 资助金额:
    $ 7.96万
  • 项目类别:
    ARC Future Fellowships
Collaborative Research: FuSe: Indium selenides based back end of line neuromorphic accelerators
合作研究:FuSe:基于硒化铟的后端神经形态加速器
  • 批准号:
    2328741
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
    Continuing Grant
Collaborative Research: NSFGEO-NERC: MEZCAL: Methods for Extending the horiZontal Coverage of the Amoc Latitudinally and back in time (MEZCAL)
合作研究:NSFGEO-NERC:MEZCAL:扩展 Amoc 纬度和时间回水平覆盖范围的方法 (MEZCAL)
  • 批准号:
    2409764
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
    Standard Grant
Relationships Between Pain-Related Psychological Factors, Gait Quality, and Attention in Chronic Low Back Pain
慢性腰痛中疼痛相关心理因素、步态质量和注意力之间的关系
  • 批准号:
    10679189
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
The Role of VEGF in the Development of Low Back Pain Following IVD Injury
VEGF 在 IVD 损伤后腰痛发展中的作用
  • 批准号:
    10668079
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression
裸盖菇素与慢性腰痛和抑郁症的情感功能
  • 批准号:
    10626449
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex
慢性腰痛的脑机制:衰老和性别的特异性和影响
  • 批准号:
    10657958
  • 财政年份:
    2023
  • 资助金额:
    $ 7.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了